alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease
- PMID: 16604306
- DOI: 10.1007/s00702-006-0435-4
alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease
Abstract
Increased alpha-synuclein expression may be involved in the pathogenesis of Parkinson's disease (PD). We investigated the association of Rep1 microsatellite and RsaI T-to-C substitution in the alpha-synuclein promoter region with the risk of PD by a case-control study. The RsaI C/C genotype and C allele were found less frequently in PD patients than in controls. A reduced risk of the Rep1-RsaI 0-C haplotype (OR = 0.57, 95% CI = 0.36-0.90) with PD was evident. The quantitative real-time PCR study showed that the alpha-synuclein mRNA expression was increased (although not significantly) in PD patients with RsaI T/T genotype or Rep1-RsaI 0-T haplotype as compared to T/C genotype or 0-C haplotype. Reporter constructs containing the RsaI C allele drove significantly lower transcriptional activity compared with the RsaI T allele in both IMR32 and 293 cells. The findings suggest that the RsaI T-to-C substitution may have a functional relevance to the susceptibility to PD.
Similar articles
-
Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.Mov Disord. 2006 Apr;21(4):534-9. doi: 10.1002/mds.20752. Mov Disord. 2006. PMID: 16250025
-
Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability.Neurosci Lett. 2003 Jan 9;336(1):70-2. doi: 10.1016/s0304-3940(02)01178-3. Neurosci Lett. 2003. PMID: 12493604
-
[The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Aug;21(4):339-41. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004. PMID: 15300629 Chinese.
-
SNCA REP1 and Parkinson's disease.Neurosci Lett. 2018 Aug 24;682:79-84. doi: 10.1016/j.neulet.2018.05.043. Epub 2018 May 30. Neurosci Lett. 2018. PMID: 29859327 Review.
-
Functional parkin promoter polymorphism in Parkinson's disease: new data and meta-analysis.J Neurol Sci. 2011 Mar 15;302(1-2):68-71. doi: 10.1016/j.jns.2010.11.023. Epub 2010 Dec 21. J Neurol Sci. 2011. PMID: 21176923 Review.
Cited by
-
Transcriptional dysregulation in a transgenic model of Parkinson disease.Neurobiol Dis. 2008 Mar;29(3):515-28. doi: 10.1016/j.nbd.2007.11.008. Epub 2007 Nov 28. Neurobiol Dis. 2008. PMID: 18191405 Free PMC article.
-
Mitochondrial DNA polymorphisms and the risk of Parkinson's disease in Taiwan.J Neural Transm (Vienna). 2007;114(8):1017-21. doi: 10.1007/s00702-007-0658-z. Epub 2007 Mar 15. J Neural Transm (Vienna). 2007. PMID: 17357825
-
The Emerging Role of the Lysosome in Parkinson's Disease.Cells. 2020 Nov 2;9(11):2399. doi: 10.3390/cells9112399. Cells. 2020. PMID: 33147750 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical